Literature DB >> 18272317

Open repair of juxtarenal aortic aneurysms (JAA) remains a safe option in the era of fenestrated endografts.

Andrew W Knott1, Manju Kalra, Audra A Duncan, Nanette R Reed, Thomas C Bower, Tanya L Hoskin, Gustavo S Oderich, Peter Gloviczki.   

Abstract

OBJECTIVES: Widespread application of infrarenal endovascular aneurysm repair (EVAR) has resulted in a proportionate increase in open juxtarenal aortic aneurysm (JAA) repairs. Fenestrated endograft technology for JAA is developing rapidly, but only limited outcomes are known. The aim of this study was to review our open JAA experience in an era of fenestrated endograft technology, identify factors associated with increased surgical risk, determine early and midterm outcome, and provide a basis for comparison for future endovascular procedures.
METHODS: Data from 126 consecutive patients who underwent elective JAA repair requiring suprarenal aortic clamping from 2001 to 2006 were analyzed retrospectively. Electronic medical chart reviews were used to record 30-day complication rates. Multivariate analyses were performed to identify risk factors associated with surgical morbidity. Mail-out questionnaires and telephone surveys were conducted to determine long-term follow-up.
RESULTS: Ninety-eight males and 28 females (median age 74 years; range 55 to 93) were included in the study. Preoperative risk factors included: coronary artery disease (CAD) 58%, pulmonary disease 41%, renal insufficiency (serum creatinine [Cr] > 1.5mg/dL) 17%, and diabetes 9%. Fifteen patients underwent concomitant renal artery revascularization. Mean operative time was 319 minutes (range 91 to 648). Thirty-day mortality was 1/126 (0.8%). Median hospital length of stay was 7 days (range 3 to 85); median intensive care unit length of stay was 2 days (1 to 64). Complications included renal insufficiency (Cr increase > 0.5 mg/dL) in 22 (18%), cardiac in 17 (13%), and pulmonary in 14 (11%). Five patients required temporary hemodialysis; only one after hospital dismissal. Mean follow-up was 48 months (range 9-80). On multivariate analysis, age > or = 78 years (P = .001), male gender (P = .04), hypertension (P =.01), previous myocardial infarction (P = .047), and diabetes (P =.009) were predictive of cardiac complications. Renal artery revascularization (P = .01) and prior MI (P = .04) were multivariate predictors of pulmonary complications. Both prolonged operative (> or =351 minutes, P = .02) and renal ischemia (> or =23 minutes, P =.004) times predicted postoperative renal insufficiency. One, 3, and 5-year cumulative survival rates were 93.9%, 78.3%, and 63.8%, respectively and were not significantly different than an age- and gender-matched sample of the US population (P = .16). Mortality was not predicted by any specific risk factors.
CONCLUSIONS: Open surgical repair of JAA is associated with low mortality and remains the gold standard. Although 18% had renal complications, only one patient had permanent renal failure. Patients with a combination of physiologic and anatomic risk factors identified on multivariate analysis may benefit from fenestrated endograft repair.

Entities:  

Mesh:

Year:  2008        PMID: 18272317     DOI: 10.1016/j.jvs.2007.12.007

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  22 in total

1.  Open treatment versus endovascular repair for aortic abdominal aneurysm-keeping the balance.

Authors:  Wtgj Bos; T Cohen; G Vourliotakis; Mrhm van Sambeek; Elg Verhoeven
Journal:  Ann Vasc Dis       Date:  2009-12-14

2.  Surgical Repair of Juxtarenal Abdominal Aortic Aneurysms and safety of Suprarenal Aortic Clamping.

Authors:  Seonjeong Jeong; Tae-Won Kwon; Youngjin Han; Yong-Pil Cho
Journal:  World J Surg       Date:  2020-06       Impact factor: 3.352

Review 3.  Management of Aortic Aneurysms: Is Surgery of Historic Interest Only?

Authors:  J Michael Bacharach; Emily A Wood; David P Slovut
Journal:  Curr Cardiol Rep       Date:  2015-11       Impact factor: 2.931

4.  Predictive factors for mortality after open repair of paravisceral abdominal aortic aneurysm.

Authors:  Prateek K Gupta; Jason N Mactaggart; Bala Natarajan; Thomas G Lynch; Shipra Arya; Himani Gupta; Xiang Fang; Iraklis I Pipinos
Journal:  J Vasc Surg       Date:  2011-12-30       Impact factor: 4.268

Review 5.  Epidemiology, outcomes, and management of acute kidney injury in the vascular surgery patient.

Authors:  Charles Hobson; Nicholas Lysak; Matthew Huber; Salvatore Scali; Azra Bihorac
Journal:  J Vasc Surg       Date:  2018-06-28       Impact factor: 4.268

6.  Patient selection and perioperative outcomes are similar between targeted and nontargeted hospitals (in the National Surgical Quality Improvement Program) for abdominal aortic aneurysm repair.

Authors:  Peter A Soden; Sara L Zettervall; Klaas H J Ultee; Jeremy D Darling; John C McCallum; Allen D Hamdan; Mark C Wyers; Marc L Schermerhorn
Journal:  J Vasc Surg       Date:  2016-07-25       Impact factor: 4.268

7.  A perioperative strategy for abdominal aortic aneurysm in patients with chronic renal insufficiency.

Authors:  Makoto Haga; Katsuyuki Hoshina; Kunihiro Shigematsu; Toshiaki Watanabe
Journal:  Surg Today       Date:  2015-12-08       Impact factor: 2.549

8.  Temporary extracorporeal axillo-iliac vascular prosthesis shunt in open repair of a pararenal aortic aneurysm.

Authors:  Einar Dregelid
Journal:  Int J Surg Case Rep       Date:  2013-01-28

9.  Long-term survival and quality of life after open abdominal aortic aneurysm repair.

Authors:  Tim K Timmers; Joost A van Herwaarden; Gert-Jan de Borst; Frans L Moll; Luke P H Leenen
Journal:  World J Surg       Date:  2013-12       Impact factor: 3.352

10.  Exclusion of complex aortic aneurysm with chimney endovascular aortic repair is applicable in a minority of patients treated with fenestrated endografts.

Authors:  Miriam Kliewer; Elisabeth Pelanek-Völk; Markus Plimon; Fadi Taher; Afshin Assadian; Jürgen Falkensammer
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-04-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.